Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study. - Wang XX; Gao Y; Jin J; Cao JN; Feng JF; Wang HQ; Zhang HL; Cai QQ; Li ZM; Jiang WQ; Huang HQ (Annals of hematology, 2021)